“Male in their 20s for thrombosis after vaccination, subject to additional analysis by EMA”

It is known that the 20 cases of cerebral blood clots found after receiving AstraZeneca (AZ)’s novel coronavirus infection (Corona 19) vaccine fall under the’Cautions’ for vaccination announced by the European Medicines Agency (EMA).

At a regular online briefing on the 20th, Park Young-joon, head of the adverse reaction investigation support team, said, “The result of the MRI (magnetic resonance imaging) test was confirmed as a cerebral vein thrombus.” I confirmed the findings that I could be suspicious of ),” he explained. CVST is a symptom of blood clotting (thrombosis) occurring in the venous sinus of the brain, which prevents blood from escaping from the brain and destroys blood cells.The European Medicines Agency (EMA) said that it will conduct further analysis without excluding the association with AstraZeneca vaccination. This is one of the cases revealed.

The previous day, EMA maintained the recommendation for approval, saying, “As a result of review regarding thrombosis cases that occurred after vaccination with Astra vaccination, it is a safe and effective vaccine,” and reaffirmed its existing position that it is’no vaccine-to-thrombosis’.

“We are currently testing the causative factor,” Park said. “We will evaluate the relevance (with the vaccination) through the trial (if the results are found) and the provincial rapid response team, and then the damage investigation team.” At the same time, EMA has reaffirmed that although the causality between the AstraZeneca vaccine and the very rare occurrence of thrombosis is not ruled out, there are currently no plans to change the vaccination schedule.

Previously, this patient was the first responder of Corona 19 and received AstraZeneca vaccine on March 10. After vaccination, I had headache and chills, and on the 14th, vomiting was accompanied, so I was treated at a medical institution on the 15th. As a result of conducting blood tests and imaging medical tests during treatment, thrombosis and brain lesions were confirmed. Initially, this patient was reported to have an adverse reaction due to inpatient treatment for headache, but as a result of thrombosis, this symptom was also reported to the adverse reaction reporting system.

[김규리 매경닷컴 기자 [email protected]]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]